Llwytho...
Prediction of Adeno-Associated Virus Neutralizing Antibody Activity for Clinical Application
Patients with neutralizing antibodies (Nab) against adeno-associated virus (AAV) are usually excluded from treatment with AAV vectors. To develop a standard assay for detecting Nab inhibition activity, we systematically studied current AAV Nab assays in vitro and in vivo. Several factors were found...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Gene Ther |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4670282/ https://ncbi.nlm.nih.gov/pubmed/26125606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2015.69 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|